Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

Esta versión no es la más reciente

ver la versión actual 09 mayo 2018

Información

DOI:
https://doi.org/10.1002/14651858.CD009069.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 30 diciembre 2013see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Marc Arbyn

    Correspondencia a: Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium

    [email protected]

  • Andrew Bryant

    Institute of Health & Society, Newcastle University, Newcastle upon Tyne, UK

  • Pierre PL Martin‐Hirsch

    Gynaecological Oncology Unit, Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, Preston, UK

  • Lan Xu

    Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium

  • Cindy Simoens

    Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium

  • Lauri Markowitz

    ESB/DSTDP/NCHHSTP, Centers for Disease Control and Prevention, Atlanta, USA

Contributions of authors

Conception of the systematic review: M. Arbyn, L Markowitz, P. Martin‐Hirsch
Study design: M. Arbyn
Retrieval of references: M. Arbyn, P. Martin‐Hirsch.
Checking eligibility of references: M. Arbyn, A Bryant, P. Martin‐Hirsch.
Extraction of data: M. Arbyn, A. Bryant, C. Simoens, L. Xu
Statistical analysis: M. Arbyn, A. Bryant, C. Simoens
Writing of the protocol: M. Arbyn, A. Bryant, C. Simoens

Sources of support

Internal sources

  • Scientific Institute of Public Health (Brussels), Belgium.

    Bibliographic support to obtain literature references, secretarial and logistic support in organising contacts and meetings with co‐authors and to store and sort bibliographic references. references

External sources

  • Department of Health, UK.

    NHS Cochrane Collaboration programme Grant Scheme CPG‐506.

  • Gynaecological Cancer Cochrane Collaboration Review Group (Bath), UK.

    Financial support to conduct four Cochrane reviews.

  • European Cancer Network and the European Co‐operation on development and implementation of Cancer screening and prevention Guidelines (ECCG), via the International Agency for Research on Cancer, Lyon), France. Financial support received from the European Commission (DG SANCO, Luxembourg) for the production of guidelines for cervical cancer screening and HPV vaccination., France.

    Financial support received from the European Commission (DG SANCO, Luxembourg) for the production of guidelines for cervical cancer screening and HPV vaccination.

  • Belgian Foundation Against Cancer (Brussels), Belgium.

    Financial support to conduct methodological research on evaluation of emerging screening methods and to continue systematic reviews on cervical cancer prevention methods.

  • IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders, Brussels, project number 060081), Belgium.

    Financial support to collect data for mathematical modelling of HPV infection (natural history, cost‐effectiveness of HPV screening and vaccination).

Declarations of interest

MA: has received travel grants from MSD‐Sanofi‐Pasteur and GSK, (ceased in 2008). AB: no conflict of interest. PM‐H: travel grants received from GSK and MSD‐Sanofi‐Pasteur. LX: no conflict of interest. CS received travel grant from GSK. LM; no conflict of interest.

Acknowledgements

We would like to acknowledge the input of the following individuals in the development of the protocol for this review: J Dillner, E. Paraskevaidis, P. Beutels, M Steben, A Schneider, A Kauffman, Z‐H Zhao, Y‐L. Qiao, P Beutels and A Hildesheim. We thank Jane Hayes for designing the search strategy and Gail Quinn and Clare Jess for their contribution to the editorial process.

Version history

Published

Title

Stage

Authors

Version

2018 May 09

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

Review

Marc Arbyn, Lan Xu, Cindy Simoens, Pierre PL Martin‐Hirsch

https://doi.org/10.1002/14651858.CD009069.pub3

2013 Dec 30

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

Protocol

Marc Arbyn, Andrew Bryant, Pierre PL Martin‐Hirsch, Lan Xu, Cindy Simoens, Lauri Markowitz

https://doi.org/10.1002/14651858.CD009069.pub2

2011 Apr 13

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

Protocol

Marc Arbyn, Andrew Bryant, Philippe Beutels, Pierre PL Martin‐Hirsch, Evangelos Paraskevaidis, Elke Van Hoof, Marc Steben, Youlin Qiao, Fang‐Hui Zhao, Achim Schneider, Andreas Kaufmann, Joakim Dillner, Lauri Markowitz, Allan Hildesheim

https://doi.org/10.1002/14651858.CD009069

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Adolescent; Adult; Female; Humans; Middle Aged; Pregnancy; Young Adult;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.